| Tau proteolysis in the pathogenesis of tauopathies: neurotoxic fragments and novel biomarkers JP Quinn, NJ Corbett, KAB Kellett, NM Hooper Journal of Alzheimer's Disease 63 (1), 13-33, 2018 | 158 | 2018 |
| The involvement of tau in nucleolar transcription and the stress response MB Maina, LJ Bailey, S Wagih, L Biasetti, SJ Pollack, JP Quinn, ... Acta neuropathologica communications 6, 1-13, 2018 | 94 | 2018 |
| VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases JP Quinn, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle Brain communications 3 (4), fcab261, 2021 | 47 | 2021 |
| Increased levels of the synaptic proteins PSD-95, SNAP-25, and Neurogranin in the cerebrospinal fluid of patients with Alzheimer’s Disease SEA Pia Kivisäkk, Becky C Carlyle, Thadryan Sweeney, James P Quinn ... Alzheimer's Research and Therapy, 2022 | 36* | 2022 |
| Responses to 10 common criticisms of anti-racism action in STEMM ML Gosztyla, L Kwong, NA Murray, CE Williams, N Behnke, P Curry, ... PLoS Computational Biology 17 (7), e1009141, 2021 | 29 | 2021 |
| Tau diagnostics and clinical studies I Gozes, G Höglinger, JP Quinn, NM Hooper, K Höglund Journal of Molecular Neuroscience 63, 123-130, 2017 | 11 | 2017 |
| Cerebrospinal fluid and brain proteoforms of the granin neuropeptide family in Alzheimer’s disease JP Quinn, EC Ethier, A Novielli, A Malone, CE Ramirez, L Salloum, ... Journal of the American Society for Mass Spectrometry 34 (4), 649-667, 2023 | 8 | 2023 |
| Age-Dependent Increase in Tau Phosphorylation at Serine 396 in Huntington’s Disease Prefrontal Cortex T Petrozziello, S Huntress, A Castillo-Torres, J Quinn, T Connors, C Auger, ... Journal of Huntington's Disease 12 (3), 267-281, 2023 | 2 | 2023 |
| Characterization of novel neuropeptide proteolytic processing involved in dementia pathophysiology EC Ethier, JP Quinn, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle Alzheimer's & Dementia 17, e058553, 2021 | | 2021 |
| Characterizing proteoforms of the granin family of neuropeptides in dementia pathophysiology JP Quinn, EC Ethier, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle Alzheimer's & Dementia 17, e056265, 2021 | | 2021 |
| Characterizing chromogranin and secretogranin proteoforms in dementia pathophysiology: Molecular and cell biology/neurodegeneration and neuroprotection JP Quinn, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle Alzheimer's & Dementia 16, e044624, 2020 | | 2020 |
| Characterizing chromogranin and secretogranin proteoforms in dementia pathophysiology JP Quinn, SE Kandigian, BA Trombetta, SE Arnold, BC Carlyle 2020 Alzheimer's Association International Conference, 2020 | | 2020 |
| P4‐524: PROTEOLYTIC CLEAVAGE OF TAU IN CORTICOBASAL DEGENERATION AND PROGRESSIVE SUPRANUCLEAR PALSY PATHOGENESIS JP Quinn, T Katsinelos, NJ Corbett, W Nickel, KA Kellett, NM Hooper Alzheimer's & Dementia 15, P1514-P1515, 2019 | | 2019 |
| O1‐06‐06: PROTEOLYTIC CLEAVAGE OF TAU IN DEMENTIA PATHOGENESIS JP Quinn, NJ Corbett, KA Kellett, NM Hooper Alzheimer's & Dementia 14 (7S_Part_4), P232-P232, 2018 | | 2018 |
| P3‐230: IDENTIFICATION OF A PLASMA PROTEIN SIGNATURE FOR ALZHEIMER'S DISEASE JP Quinn, KA Kellett, NJ Corbett, DC Lee, B Geary, AD Whetton, ... Alzheimer's & Dementia 14 (7S_Part_22), P1159-P1159, 2018 | | 2018 |
| Tau Proteolysis–Mechanisms and Relevance for Tauopathies JP Quinn PQDT-Global, 2018 | | 2018 |
